On Apr. 22, 2020, BioNTech and Pfizer announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the…
On Apr. 21, 2020, Vaxart announced it had obtained positive pre-clinical results for its COVID-19 vaccine candidates, with…
On Apr. 20, 2020, VGX signed as the first occupant of Conroeﾒs Deison Technology Park and will move…
On Apr. 17, 2020, five projects from across Oxford University’s Medical Sciences Division were among twenty-one new studies…
On Apr. 17, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that older adults were being enrolled…
On Apr. 17, 2020, Sinovac Biotech announced that the Company had commenced Phase I clinical trial, a randomized,…
On Apr. 17, 2020, Emory University announced it had begun enrolling adults over age 55 in the clinical…
On Apr. 17, 2020, Celdara Medical announced that it had entered into a Cooperative Research and Development Agreement…
On Apr. 16, 2020, the International Vaccine Institute (IVI) announced that the Coalition for Epidemic Preparedness Innovations (CEPI)…
On Apr. 16, 2020, Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare announced a consortium that…
On Apr. 16, 2020, Moderna announced an agreement for a commitment of up to $483 million from the…
On Apr. 16, 2020, Soligenix announced it has executed an agreement for the exclusive worldwide license of CoVaccine…
On Apr. 15, 2020, Abbott announced the launch of its third COVID-19 test, a lab-based serology blood test…
On Apr. 15, 2020, HALIX announced it had joined a consortium of partners under the guidance of the…
On Apr. 15, 2020, the Bill & Melinda Gates Foundation announced an expansion of its funding for the…
On Apr. 14, 2020, researchers from the University of Pittsburgh announced that they had adapted a system to…
On Apr. 14, 2020, Sanofi and GSK announced that they had signed a letter of intent to enter…
On Apr. 14, 2020, Sinovac Biotech announced that the Company had obtained approval to conduct a human clinical…
On Apr. 14, 2020, the Jackson Laboratory (JAX) in collaboration with several Maine regional hospitals, announced additional coronavirus…
On Apr. 10, 2020, the Institute for Health Metrics and Evaluation (IHME) released updated COVID-19 predictions for deaths…
On Apr. 9, 2020, Pfizer and BioNTech disclosed additional details of their collaboration to advance candidates from BioNTech’s…
On Apr. 9, 2020, iBio announced the signing of two agreements with the Infectious Disease Research Institute (IDRI)…
![Dynavax donated 10,000 doses of HEPLISAV-Bﾮ [Hepatitis B Vaccine (Recombinant), adjuvanted] vaccine to emergency healthcare providers](https://www.lifesciencehistory.com/wp-content/uploads/2024/05/dynavax_logo-3.png){kind=logo}
On Apr. 8, 2020, Dynavax Technologies announced it had donated 10,000 doses of HEPLISAV-B adult vaccine to help…
On Apr. 8, 2020, Novavax announced it had identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein…
On Apr. 8, 2020, Pacific Biosciences announced it is working with commercial, academic and government research teams that…
On Apr. 7, 2020, the Queensland University of Technology (QUT) announced that it is leading an international team…
On Apr. 7, 2020, Researchers at the University of Iowa and the University of Georgia announced they had…
On Apr. 7, 2020, the University of Washington Medicine (UW) announced that more than $20 million has been…
On Apr. 6, 2020, OncoSec Medical announced that Providence Cancer Institute, a part of Providence St. Joseph Health…
On Apr. 6, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced its participation in a clinical trial…